Hospital Carlos III-ko ikertzaileekin lankidetzan egindako argitalpenak (8)

2021

  1. Demographic, clinical, and functional determinants of antithrombotic treatment in patients with nonvalvular atrial fibrillation

    BMC Cardiovascular Disorders, Vol. 21, Núm. 1

2016

  1. Association of triglycerides and new lipid markers with the incidence of hypertension in a Spanish cohort

    Journal of Hypertension, Vol. 34, Núm. 7, pp. 1257-1265

  2. Triglyceride-glucose index (TyG index) in comparison with fasting plasma glucose improved diabetes prediction in patients with normal fasting glucose: The Vascular-Metabolic CUN cohort

    Preventive Medicine, Vol. 86, pp. 99-105

2015

  1. Novedades cardiovasculares 2013/2014

    Revista Clinica Espanola, Vol. 215, Núm. 1, pp. 33-42

2014

  1. Unanswered clinical questions in the management of cardiometabolic risk in the elderly: A statement of the Spanish society of internal medicine

    BMC Cardiovascular Disorders, Vol. 14, Núm. 1

2013

  1. What was new about vascular risk in the year 2012?

    Revista Clinica Espanola, Vol. 213, Núm. 9, pp. 442-452

2011

  1. Pathogenesis of occult chronic hepatitis B virus infection

    World Journal of Gastroenterology, Vol. 17, Núm. 12, pp. 1543-1548

2007

  1. Prevalencia de enfermedad arterial periférica estimada mediante el índice tobillo-brazo en pacientes con síndrome metabólico. Estudio MERITO I

    Revista Clinica Espanola, Vol. 207, Núm. 5, pp. 228-233